Elekta purchases French surgical robotic developer
This article was originally published in Clinica
The Swedish manufacturer of minimally invasive neurological devices, Elekta, has acquired the remaining 82% of the shares of DeeMed International for SKr 35 million ($5.2 million). DeeMed is a French development company in surgical robotic technology. Elekta and DeeMed have co-operated for the past three years to develop SurgiScope, a robotic, computer-controlled surgical microscope, which was launched in Europe last year. An approval application for SurgiScope has been submitted to the US FDA.
You may also be interested in...
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.